These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8631373)

  • 21. Extracellular matrix is required for MAP kinase activation and proliferation of rat glomerular epithelial cells.
    Cybulsky AV; McTavish AJ
    Biochem Biophys Res Commun; 1997 Feb; 231(1):160-6. PubMed ID: 9070241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.
    Sohaskey ML; Ferrell JE
    Mol Biol Cell; 1999 Nov; 10(11):3729-43. PubMed ID: 10564268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ; Kahn CR
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of phosphoprotein phosphatases 1 and 2A cause activation of a 53 kDa protein kinase accompanying the apoptotic response of breast cancer cells.
    Rossini GP; Pinna C; Viviani R
    FEBS Lett; 1997 Jun; 410(2-3):347-50. PubMed ID: 9237660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF.
    Xing C; Imagawa W
    Carcinogenesis; 1999 Jul; 20(7):1201-8. PubMed ID: 10383890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
    Winston JT; Olashaw NE; Pledger WJ
    J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parietal cell MAP kinases: multiple activation pathways.
    Nakamura K; Zhou CJ; Parente J; Chew CS
    Am J Physiol; 1996 Oct; 271(4 Pt 1):G640-9. PubMed ID: 8897883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
    Hulley PA; Gordon F; Hough FS
    Endocrinology; 1998 May; 139(5):2423-31. PubMed ID: 9564854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells.
    Parameswaran N; Nambi P; Hall CS; Brooks DP; Spielman WS
    Eur J Pharmacol; 2000 Jan; 388(2):133-8. PubMed ID: 10666504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase.
    Samuels ML; Weber MJ; Bishop JM; McMahon M
    Mol Cell Biol; 1993 Oct; 13(10):6241-52. PubMed ID: 8413224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
    Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
    Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Okadaic acid-induced hyperphosphorylation of the epidermal growth factor receptor. Comparison with receptor phosphorylation and functions affected by another tumor promoter, 12-O-tetradecanoylphorbol-13-acetate.
    Hernández-Sotomayor SM; Mumby M; Carpenter G
    J Biol Chem; 1991 Nov; 266(31):21281-6. PubMed ID: 1657956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of MAP kinases in growth responsive pancreatic cancer cells.
    Douziech N; Calvo E; Lainé J; Morisset J
    Cell Signal; 1999 Aug; 11(8):591-602. PubMed ID: 10433520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells.
    Gotoh Y; Nishida E; Yamashita T; Hoshi M; Kawakami M; Sakai H
    Eur J Biochem; 1990 Nov; 193(3):661-9. PubMed ID: 2174361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence and regulation of Raf-1-K (Kinase), MAPK-K, MAP-K, and S6-K in rat nephron segments.
    Terada Y; Yamada T; Takayama M; Nonoguchi H; Sasaki S; Tomita K; Marumo F
    J Am Soc Nephrol; 1995 Dec; 6(6):1565-77. PubMed ID: 8749682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons.
    Mao L; Yang L; Arora A; Choe ES; Zhang G; Liu Z; Fibuch EE; Wang JQ
    J Biol Chem; 2005 Apr; 280(13):12602-10. PubMed ID: 15661743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dependence of Mos-induced Cdc2 activation on MAP kinase function in a cell-free system.
    Huang CY; Ferrell JE
    EMBO J; 1996 May; 15(9):2169-73. PubMed ID: 8641282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
    Shen SC; Ko CH; Hsu KC; Chen YC
    Int J Cancer; 2004 Feb; 108(4):502-10. PubMed ID: 14696113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.